Lexaria Bioscience Corp.

NASDAQ: LEXX
Nasdaq Stock Market
Healthcare Biotechnology
Global Rank
#43019
Country Rank
#1648
Market Cap
9.06 M
Price
5.48
Change (%)
2.49%
Volume
72,231

Lexaria Bioscience Corp. (NASDAQ: LEXX) Stock Split History

Date Split Ratio Multiple Cumulative multiple Type
08/03/2026 1:15 x0.06666667 x0.0006111112 Reverse
01/12/2021 1:30 x0.03333334 x0.009166667 Reverse
12/16/2015 1.1:1 x1.1 x0.275 Forward
06/23/2009 1:4 x0.25 x0.25 Reverse

Frequently Asked Questions

  • How much would Lexaria Bioscience Corp. stock be worth if it never split?
    If Lexaria Bioscience Corp. (stock symbol: NASDAQ: LEXX) had never undergone any stock splits, its price per share today would be approximately 0.00 USD. This calculation reflects the cumulative effect of all splits, including the most recent split (ratio: 1-for-15) that occurred on 08/03/2026.
  • Lexaria Bioscience Corp. (stock symbol: NASDAQ: LEXX) has undergone a total of four stock splits. The most recent split occurred on 08/03/2026. One share bought prior to the first split on 06/23/2009 would now equal 0.00 shares.
  • Lexaria Bioscience Corp. (stock symbol: NASDAQ: LEXX) has undergone four stock splits in its history. The most recent split, a 1-for-4 split, occurred on 08/03/2026. While future splits are not guaranteed, significant increases in stock price could prompt consideration for another split.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Research Tools

Copyright © 2026. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.